Hemic and Lymphatic Diseases

593 trials 238 recruiting

Filter these 593 trials by phase, country and sponsor.

Open in Search →

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors Recruiting

2022-500470-33-00 Haemophilia 5 2022-11-14
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination… Recruiting

2023-503442-30-00 Multiple Myeloma 5 2022-10-14
The study's aim is to treat adult patients affected by Ph-like ALL, a Philadelphianegative ALL subtype, with a combination of the tyrosine k… Recruiting

2023-510240-20-00 Adult Philadelphia Chromosome-Negative Acute Lymphoblas 4 2022-10-05
DK-CLIC-1901 CAR T-cells for treatment of patients with relapsed/refractory CD19 positive hematological malignancies (DAN-CART 1901) Recruiting

2024-515174-27-00 Acute Lymphoblastic Leukemia and B-cell Non Hodgkin Lym 4 2022-10-03
Pharmacokinetic-guided dosing of emicizumab in congenital haemophilia A patients – The DosEmi study Recruiting

2024-515528-35-00 Congenital Haemophilia A 11 2022-09-08
A study to Investigate the efficacy and safety of Depemokimab compared with placebo in Adults with Hypereosinophilic Syndrome (HES) Recruiting

2023-510346-25-00 Hypereosinophilic Syndrome (HES) 5 2022-09-01
A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia Recruiting

2023-503335-18-00 Chronic myeloid leukemia 1 2022-07-29
Monalizumab infusion in patients with acute myeloid leukemia or myelodysplastic syndrome undergoing haploidentical hematopoietic stem cell t… Recruiting

2024-516974-31-00 Patients with acute myeloid leukemia or myelodysplastic 4 2022-07-22
An Open Label, Phase 2 Study to Evaluate Activity and Safety of Daratumumab in combination with Bortezomib and Dexamethasone in patients wit… Recruiting

2024-511635-94-00 Relapsed or Refractory Plasmablastic lymphoma 4 2022-07-11
Early Stage Follicular LymphOma and RadioTherapy PLUS anti-CD20 Antibody Recruiting

2023-509278-41-00 Early Stage Follicular LymphOma 5 2022-07-04
Studying Conditioning Regimen In Pediatric Transplantation -AML Recruiting

2023-505512-37-00 Acute Myeoloid Leukemia 5 2022-06-07
A randomized phase I/ II multicenter study evaluating combination of luspatercept in LR-MDS without RS having failed or being ineligible to … Recruiting

2024-515354-24-00 Low risk myelodysplastic syndrom without RS having fail 9 2022-05-18
Fecal Microbiota Transplantation in the prevention of complications after allogeneic hematopoietic stem cell transplantation for hematologic… Recruiting

2024-512969-14-01 Patient who underwent Allogeneic hematopoietic stem cel 4 2022-05-02
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants Wi… Recruiting

2023-504599-10-00 Chronic lymphocytic leukemia recurrent 4 2022-03-29
Study of BGB-11417 in Patients with Myeloid Malignancies Recruiting

2023-508881-14-00 Myeloid malignancies (acute myeloid leukemia (AML), mye 9 2022-03-21
Pre- vs. postoperative thromboprophylaxis for liver resection – a prospective, multicentre, randomized controlled trial (PREPOSTEROUS trial) Recruiting

2024-519726-20-00 Liver surgery 6 2022-03-17
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituxim… Recruiting

2024-510690-16-00 Relapsed/refractory follicular lymphoma 5 2022-01-31
Phase 1 trial of trametinib and gilteritinib for the treatment of relapsed or refractory acute leukemia patients Recruiting

2024-518301-18-00 Relapsed and/or refractory acute lymphoblastic (ALL) or 3 2022-01-28
STOP-LEUKEMIA: Repurposing metformin as a leukemia-preventive drug in CCUS and LR-MDS Recruiting

2024-518436-37-01 Myelodysplastic syndromes (MDS), very low- and low-risk 4 2021-12-01
An Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of … Recruiting

2024-518263-35-00 Primary plasma cell leukemia 4 2021-11-23
NMDSG-14B2 Recruiting

2024-511651-17-00 Myelodysplastic syndrome 4 2021-09-21
A dose escalation followed by dose expansion trial to assess safety and tolerability of CAP-100 in subjects with relapsed/refractory chronic… Recruiting

2024-516341-39-00 Relapsed/refractory chronic lymphocytic leukemia (CLL) 1 2021-08-23
The SABLe study Recruiting

2024-512276-35-00 Multiple Myeloma 4 2021-08-09
IFM2020-05-BENEFIT-Multicenter Open label Phase 3 study of Isatuximab plus Lenalidomide and Dexamethasone with/without Bortezomib in the Tre… Recruiting

2024-517215-67-00 Newly diagnosed Non-Frail transplant Ineligible Multipl 5 2021-06-11